Tarlenib - analogs
Components: Erlotinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: — Instructions Tarlenib | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Phenindione ✘ (incl) MV-Formula ✘ (incl) Pasta Hydroxyapatiti ✘ (incl) Lotonel ✘ (incl) Homeopathic medicine from Polcortolone ✘ (incl) Пензитал Гастро ✘ (incl) Jarrow Formulas Jarro-Dophilus Baby ✘ (incl) Красный корень-плюс серии «Радуга Горного Алтая» ✘ (incl) ЖАБИЙ КАМЕНЬ ХОНДРОПРОТЕКТОР ✘ (incl) Algeldrate ✘ (incl) Максиферт ✘ (incl) Thymi vulgaris herba ✘ (incl) Fagus orientalis ✘ (incl) Phosphabensidum ✘ (incl) Superum Кальций Д3 ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Tarceva neutral | 838€ |
≈100% | Erlotinib neutral | — |
≈100% | Erlotinib - native neutral | — |
≈100% | Erlotinib hydrochloride neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 59% 2535.2€ Alecensa neutral [Alectinib]
- 52% 2103.9€ Mekinist neutral [Trametinib]
- 50% — Zykadia neutral [Ceritinib]
- 50% — Осимертиниба мезилат neutral [Osimertinib]
- 50% — Осимертиниб neutral [Osimertinib]
- 50% 5550€ Tagrisso neutral [Osimertinib]
- 45% 637.5-902.1€ Giotrif neutral [Afatinib]
- 45% 1114€ Iressa neutral [Gefitinib]
- 45% — Gefitinib neutral [Gefitinib]
- 39% — Sunitinib neutral [Sunitinib]
- 39% — Лорвиква neutral [Lorlatinib]
- 39% 2016.2€ Sunitinib-nativ neutral [Sunitinib]
- 36% 447.2-480€ Alimta Dangerous 🔍 [Pemetrexed]
- 36% — Pemetrexed disodium Dangerous 🔍 [Pemetrexed]
- 36% — Фолитрекс Dangerous 🔍 [Pemetrexed]
- 36% — Пеметрекседа динатрия гептагидрат Dangerous 🔍 [Pemetrexed]
- 36% — Pemetrexed J Dangerous 🔍 [Pemetrexed]
- 36% — Пеметрексед-Рус Dangerous 🔍 [Pemetrexed]
- 36% — Verotrexed Dangerous 🔍 [Pemetrexed]
- 36% — Pemetrexed-nativ Dangerous 🔍 [Pemetrexed]
- 36% — Пеметрексед-промомед Dangerous 🔍 [Pemetrexed]
- 36% — Pemetrexed-TL Dangerous 🔍 [Pemetrexed]
- 36% 76.2-377.7€ Пемелан Dangerous 🔍 [Pemetrexed]
- 36% — Пеметрекседа динатрия гемипентагидрат Dangerous 🔍 [Pemetrexed]
- 36% — Пемджем Dangerous 🔍 [Pemetrexed]
- 36% — Антифолат Dangerous 🔍 [Pemetrexed]
- 36% — Пеметрексед Канон Dangerous 🔍 [Pemetrexed]
- 36% — ИСПОЛАТ Dangerous 🔍 [Pemetrexed]
- 36% — Пеметрексед-ДЕКО Dangerous 🔍 [Pemetrexed]
- 36% — Пеметрексед-Келун-Казфарм Dangerous 🔍 [Pemetrexed]
- 36% 407.7€ Pemetrexed Dangerous 🔍 [Pemetrexed]
- 35% 807.2-809.8€ Итулси neutral [Palbociclib]
- 35% 2701.7-2704.5€ Xalkori neutral [Crizotinib]
- 35% 862.9€ Vargatef Negative 🔍 [Nintedanib]
- 35% 798-825€ Ibrance neutral [Palbociclib]
- 35% 1199.1€ Risarg neutral [Ribociklib]
- 33% — Гефитиниб-Рус neutral [Gefitinib]
- 33% — Гефитиниб-промомед neutral [Gefitinib]
- 33% — Sorafenib neutral [Sorafenib]
- 33% — Verzenio neutral [Abemaciclib]
- 32% 250-450€ Opdivo neutral [Nivolumab]
- 32% 3936.6€ Кабометикс neutral [Cabozantinib]
- 32% 993.9-2945.6€ Caprelsa Negative 🔍 [Vandetanib]
- 30% 1732.5€ Lenvima neutral [Lenvatinib]
- 30% — Сунитиниба малат neutral [Sunitinib]
- 29% — Vinorelbine medac Dangerous 🔍 [Vinorelbine]
- 29% 830-1485.8€ Nexavar neutral [Sorafenib]
- 29% — Сорафениба тозилат neutral [Sorafenib]
- 29% — Флутриксан neutral [Sorafenib]
- 29% — Сорафениб-АМЕДАРТ neutral [Sorafenib]
Learn more about the selection of analogues
- The drug has «Tarlenib» 6 full analogs, the cheapest - Tarceva (838€); 51 analog by action, the most similar - Alecensa (2535.2€).
- Medical online service has selected the best substitutes for Tarlenib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Tarlenib analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.